Option Care Health (NASDAQ:OPCH) Raised to “Buy” at Bank of America

Option Care Health (NASDAQ:OPCH) was upgraded by investment analysts at Bank of America from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Monday. The brokerage presently has a $33.00 price objective on the stock, up from their prior price objective of $26.00. Bank of America‘s price target indicates a potential upside of 20.00% from the stock’s previous close.

OPCH has been the topic of several other reports. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Barrington Research lowered their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday. Finally, Truist Financial decreased their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.71.

Option Care Health Stock Up 14.6 %

Shares of Option Care Health stock traded up $3.51 during midday trading on Monday, hitting $27.50. The company had a trading volume of 2,739,009 shares, compared to its average volume of 1,643,684. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market capitalization of $4.68 billion, a P/E ratio of 23.11, a P/E/G ratio of 2.43 and a beta of 1.31. The company has a 50 day moving average of $23.10 and a 200 day moving average of $27.69. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.63.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

Several large investors have recently added to or reduced their stakes in OPCH. UMB Bank n.a. increased its stake in Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after acquiring an additional 750 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. grew its stake in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after buying an additional 1,446 shares during the last quarter. International Assets Investment Management LLC grew its stake in shares of Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares during the last quarter. Finally, Quarry LP grew its stake in shares of Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after buying an additional 2,628 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.